In the last decade, a large number of markers has been studied for their prognostic value in ccRCC such as carbonic anhydrase IX, p53, XIAP, HIF1-α, VEGF, and Survivin, but their clinical use remains debatable [7]. Here, HIF1A is linked to nonpapillary renal cell carcinoma.